322
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis

, , , , , , , , ORCID Icon & ORCID Icon show all
Pages 143-148 | Received 29 Sep 2021, Accepted 12 Oct 2021, Published online: 25 Oct 2021

References

  • Nishizawa T, Suzuki H. Gastric carcinogenesis and underlying molecular mechanisms: Helicobacter pylori and novel targeted therapy. Biomed Res Int. 2015;2015:794378.
  • Zhang L, Liu Y, You P, et al. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. Scand J Gastroenterol. 2018;53(7):843–848.
  • Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol. 2010;5(4):639–648.
  • Yan X, Hu X, Duan B, et al. Exploration of endoscopic findings and risk factors of early gastric cancer after eradication of Helicobacter pylori. Scand J Gastroenterol. 2021;56(3):356–362.
  • Nishizawa T, Suzuki H, Nakagawa I, et al. Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of mongolian gerbils. Digestion. 2009;79(2):99–108.
  • Nishizawa T, Yoshida S, Watanabe H, et al. Clue of diagnosis for autoimmune gastritis. Digestion. 2021. DOI:https://doi.org/10.1159/000516624.
  • Zhang H, Zhu J, Cui R, et al. Autoimmune metaplastic atrophic gastritis in chinese: a study of 320 patients at a large tertiary medical center. Scand J Gastroenterol. 2017;52(2):150–156.
  • Miceli E, Vanoli A, Lenti MV, et al. Natural history of autoimmune atrophic gastritis: a prospective, single Centre, long-term experience. Aliment Pharmacol Ther. 2019;50(11-12):1172–1180.
  • Nishiura H, Iwamoto S, Kido M, et al. Interleukin-21 and tumor necrosis factor-alpha are critical for the development of autoimmune gastritis in mice. J Gastroenterol Hepatol. 2013;28(6):982–991.
  • Minalyan A, Benhammou JN, Artashesyan A, et al. Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol. 2017;10:19–27.
  • Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol. 2002;37(3):262–266.
  • Burman P, Karlsson FA, Loof L, et al. +K-ATPase antibodies in autoimmune gastritis: observations on the development of pernicious anemia. Scand J Gastroenterol. 1991;26(2):207–214.
  • Jeong S, Choi E, Petersen CP, et al. Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis. United Euro Gastroenterol J. 2017;5(1):37–44.
  • Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–541.
  • Conti L, Lenti MV, Di Sabatino A, et al. Seronegative autoimmune atrophic gastritis is more common in elderly patients. Dig Liver Dis. 2020;52(11):1310–1314.
  • Nishizawa T, Toyoshima O, Kondo R, et al. The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis. J Clin Biochem Nutr. 2021;68(1):101–104.
  • Nishizawa T, Sakitani K, Suzuki H, et al. Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection. WJG. 2020;26(35):5354–5361.
  • Toyoshima O, Nishizawa T, Sakitani K, et al. Nodularity-like appearance in the cardia: novel endoscopic findings for Helicobacter pylori infection. Endosc Int Open. 2020;8(6):E770–E774.
  • Toyoshima O, Nishizawa T, Yoshida S, et al. Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity. World J Gastroenterol. 2020;26(34):5146–5155.
  • Strickland RG. The sydney system: auto-immune gastritis. J Gastroenterol Hepatol. 1991;6(3):238–243.
  • Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: pathologist's viewpoint. World J Gastroenterol. 2015;21(42):12179–12189.
  • Bizzaro N, Tozzoli R, Villalta D. Autoimmune diagnostics: the technology, the strategy and the clinical governance. Immunol Res. 2015;61(1-2):126–134.
  • Efe C, Torgutalp M, Henriksson I, et al. Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome. J Gastroenterol Hepatol. 2021;36(4):936–942.
  • Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. Clin Chem Lab Med. 2008;46(5):577–587.
  • Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139(5 Pt 1):346–351.
  • Tozzoli R, Kodermaz G, Perosa AR, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10(2):80–83.
  • Notsu T, Adachi K, Mishiro T, et al. Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan. Intern Med. 2019;58(13):1817–1823.
  • Massironi S, Cavalcoli F, Zilli A, et al. Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study. BMC Gastroenterol. 2018;18(1):172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.